We are live on ! Find out more
ITP

Iron Triangle Partners Portfolio holdings

AUM $875M
1-Year Est. Return 49.85%
This Fund
S&P 500
This Quarter Est. Return
+10.48%
1 Year Est. Return
+49.85%
3 Year Est. Return
+151.9%
5 Year Est. Return
+239.84%
10 Year Est. Return
–
AUM
$722M
AUM Growth
-$262M
Cap. Flow
-$303M
Cap. Flow %
-41.97%
Top 10 Hldgs %
64.42%
Holding
39
New
13
Increased
2
Reduced
10
Closed
14

Top Buys

Rank Stock Value
1
MEDP icon
Medpace
MEDP
+$73.3M
2
ILMN icon
Illumina
ILMN
+$54.3M
3
THC icon
Tenet Healthcare
THC
+$46.7M
4
NVST icon
Envista
NVST
+$38.1M
5
MMSI icon
Merit Medical Systems
MMSI
+$23.2M

Top Sells

Rank Stock Value
1
EW icon
Edwards Lifesciences
EW
+$67.2M
2
DXCM icon
DexCom
DXCM
+$66M
3
MCK icon
McKesson
MCK
+$53.8M
4
ABBV icon
AbbVie
ABBV
+$48.8M
5
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$45.7M

Sector Composition

Rank Sector Weight
1 Healthcare 98.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ABBV icon
26
AbbVie
ABBV
$454B
– –
-284,657
Closed -$48.8M
ACHC icon
27
CALL
Acadia Healthcare
ACHC
$2.99B
– –
-298,200
Closed -$20.1M
AGL icon
28
Agilon Health
AGL
$1.64B
– –
-100,777
Closed -$16.5M
ARGX icon
29
argenx
ARGX
$55.6B
– –
-61,704
Closed -$26.5M
BMRN icon
30
BioMarin Pharmaceuticals
BMRN
$11.6B
– –
-555,140
Closed -$45.7M
DXCM icon
31
DexCom
DXCM
$28.3B
– –
-582,199
Closed -$66M
EW icon
32
Edwards Lifesciences
EW
$47.8B
– –
-727,180
Closed -$67.2M
INSP icon
33
Inspire Medical Systems
INSP
$1.47B
– –
-281,992
Closed -$37.7M
MASS icon
34
908 Devices
MASS
$293M
– –
-728,865
Closed -$3.75M
MCK icon
35
McKesson
MCK
$99.5B
– –
-92,125
Closed -$53.8M
NBIX icon
36
Neurocrine Biosciences
NBIX
$17.7B
– –
-200,000
Closed -$27.5M
SDGR icon
37
Schrodinger
SDGR
$1.14B
– –
-1,133,102
Closed -$21.9M
WST icon
38
West Pharmaceutical
WST
$23.3B
– –
-132,908
Closed -$43.8M
ALMS
39
Alumis Inc
ALMS
$3.45B
– –
-125,000
Closed -$1.66M
1
2

Similar funds

8KM
8 Knots Management Dallas, Texas $868M AUM 30.97% 1-Year Est. Return
MFG
MidWestOne Financial Group Iowa City, Iowa $900M AUM 23.95% 1-Year Est. Return
NP
Ninepoint Partners Toronto, Ontario, Canada $904M AUM 39.64% 1-Year Est. Return
GGI
Galaxy Group Investments New York $843M AUM 47.48% 1-Year Est. Return
WFAL
Wedbush Fund Advisers, LLC Pasadena, California $967M AUM
OBWP
O'Brien Wealth Partners Waltham, Massachusetts $756M AUM 13.93% 1-Year Est. Return
TWM
Tolleson Wealth Management Dallas, Texas $693M AUM 17.6% 1-Year Est. Return
AGC
Angelo Gordon & Co New York $1.06B AUM 47.95% 1-Year Est. Return

Iron Triangle Partners's Q3 2024 Portfolio in Review

As of Q3 2024, Iron Triangle Partners held 39 positions worth $722M, down 27% from $984M the previous quarter. Its ten largest holdings account for 64% of the portfolio.

Iron Triangle Partners withdrew a net $303M in Q3 2024, closing 14 positions and reducing 10 holdings. Its most notable exit was Edwards Lifesciences, an estimated $67.2M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 99% of assets, up from 97% a quarter earlier.

Against the trend, Iron Triangle Partners opened a new position in Medpace worth $64.4M.

  • Iron Triangle Partners's largest Q3 2024 buy was Medpace: 192,842 shares worth $64.4M.
  • Iron Triangle Partners added most to Elanco Animal Health in Q3 2024, an estimated $14.4M increase.
  • Iron Triangle Partners's biggest Q3 2024 reduction was Glaukos, cutting an estimated $36.1M.
  • Iron Triangle Partners fully exited Edwards Lifesciences in Q3 2024, selling an estimated $67.2M.
  • Iron Triangle Partners's ten largest holdings make up 64% of its $722M portfolio in Q3 2024.
  • Iron Triangle Partners opened 13 new positions and closed 14 in Q3 2024.
  • Iron Triangle Partners's portfolio value fell 27% quarter-over-quarter to $722M.

Based on Iron Triangle Partners's 13F filing for Q3 2024, filed 14 Nov 2024.